The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis
Purpose: To explore the predictive efficacy of tumor mutation burden (TMB) as a potential biomarker for cancer patients treated with Immune checkpoint inhibitors (ICIs). Methods: We systematically searched PubMed, Cochrane Library, Embase and Web of Science for clinical studies (published between Ja...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2022-06-01
|
| סדרה: | Translational Oncology |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S1936523322000377 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
